skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Refinado por: assunto: Adult remover assunto: Tumors remover Biological And Medical Sciences remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Outcomes of patients who undergo aggressive induction therapy for secondary acute myeloid leukemia
Outcomes of patients who undergo aggressive induction therapy for secondary acute myeloid leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Outcomes of patients who undergo aggressive induction therapy for secondary acute myeloid leukemia

Rizzieri, David A. ; O'Brien, Jenny A. ; Broadwater, Gloria ; Decastro, Carlos M. ; Dev, Prakash ; Diehl, Louis ; Beaven, Anne ; Lagoo, Anand ; Gockerman, Jon P. ; Chao, Nelson J. ; Moore, Joseph O.

Cancer, 2009-07, Vol.115 (13), p.2922-2929 [Periódico revisado por pares]

Hoboken: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível

Citações Citado por
2
Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II Trial
Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II Trial

ARMAND, Philippe ; NAGLER, Arnon ; FAY, Joseph W ; RIZZIERI, David A ; HOSING, Chitra M ; BALL, Edward D ; UBERTI, Joseph P ; LAZARUS, Hillard M ; MAPARA, Markus Y ; GREGORY, Stephanie A ; TIMMERMAN, John M ; ANDORSKY, David ; WELLER, Edie A ; OR, Reuven ; WALLER, Edmund K ; ROTEM-YEHUDAR, Rinat ; GORDON, Leo I ; DEVINE, Steven M ; AVIGAN, David E ; CHEN, Yi-Bin ; KAMINSKI, Mark S ; KENT HOLLAND, H ; WINTER, Jane N ; MASON, James R

Journal of clinical oncology, 2013-11, Vol.31 (33), p.4199-4206 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
3
Pre-engraftment syndrome after myeloablative dual umbilical cord blood transplantation: risk factors and response to treatment
Pre-engraftment syndrome after myeloablative dual umbilical cord blood transplantation: risk factors and response to treatment
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pre-engraftment syndrome after myeloablative dual umbilical cord blood transplantation: risk factors and response to treatment

KANDA, J ; KAYNAR, L ; GASPARETTO, C ; CHUTE, J. P ; MORRIS, A ; WINKEL, S ; MCPHERSON, J ; KURTZBERG, J ; CHAO, N. J ; HORWITZ, M. E ; KANDA, Y ; PRASAD, V. K ; PARIKH, S. H ; LAN, L ; SHEN, T ; RIZZIERI, D. A ; LONG, G. D ; SULLIVAN, K. M

Bone marrow transplantation (Basingstoke), 2013-07, Vol.48 (7), p.926-931 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
4
Hematopoietic Stem-Cell Transplantation for Acute Leukemia in Relapse or Primary Induction Failure
Hematopoietic Stem-Cell Transplantation for Acute Leukemia in Relapse or Primary Induction Failure
Material Type:
Artigo 		Adicionar ao Meu Espaço

Hematopoietic Stem-Cell Transplantation for Acute Leukemia in Relapse or Primary Induction Failure

DUVAL, Michel ; KLEIN, John P ; KEATING, Armand ; LAZARUS, Hillard M ; LITZOW, Mark R ; MARKS, David I ; MAZIARZ, Richard T ; RIZZIERI, David A ; SCHILLER, Gary ; SCHULTZ, Kirk R ; TALLMAN, Martin S ; WEISDORF, Daniel ; WENSHENG HE ; CAHN, Jean-Yves ; CAIRO, Mitchell ; CAMITTA, Bruce M ; KAMBLE, Rammurti ; COPELAN, Edward ; DE LIMA, Marcos ; GUPTA, Vikas

Journal of clinical oncology, 2010-08, Vol.28 (23), p.3730-3738 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
5
Autologous or Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation for Chemotherapy-Sensitive Mantle-Cell Lymphoma: Analysis of Transplantation Timing and Modality
Autologous or Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation for Chemotherapy-Sensitive Mantle-Cell Lymphoma: Analysis of Transplantation Timing and Modality
Material Type:
Artigo 		Adicionar ao Meu Espaço

Autologous or Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation for Chemotherapy-Sensitive Mantle-Cell Lymphoma: Analysis of Transplantation Timing and Modality

FENSKE, Timothy S ; ZHANG, Mei-Jie ; HOLMBERG, Leona A ; INWARDS, David J ; LAZARUS, Hillard M ; MAZIARZ, Richard T ; MUNKER, Reinhold ; PERALES, Miguel-Angel ; RIZZIERI, David A ; SCHOUTEN, Harry C ; SMITH, Sonali M ; WALLER, Edmund K ; CARRERAS, Jeanette ; WIRK, Baldeep M ; LAPORT, Ginna G ; MALONEY, David G ; MONTOTO, Silvia ; HARI, Parameswaran N ; AYALA, Ernesto ; BURNS, Linda J ; CASHEN, Amanda ; COSTA, Luciano J ; FREYTES, César O ; GALE, Robert P ; HAMADANI, Mehdi

Journal of clinical oncology, 2014-02, Vol.32 (4), p.273-281 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
6
Improved efficacy using rituximab and brief duration, high intensity chemotherapy with filgrastim support for Burkitt or aggressive lymphomas: cancer and Leukemia Group B study 10 002
Improved efficacy using rituximab and brief duration, high intensity chemotherapy with filgrastim support for Burkitt or aggressive lymphomas: cancer and Leukemia Group B study 10 002
Material Type:
Artigo 		Adicionar ao Meu Espaço

Improved efficacy using rituximab and brief duration, high intensity chemotherapy with filgrastim support for Burkitt or aggressive lymphomas: cancer and Leukemia Group B study 10 002

Rizzieri, David A. ; Johnson, Jeffrey L. ; Byrd, John C. ; Lozanski, Gerard ; Blum, Kristie A. ; Powell, Bayard L. ; Shea, Thomas C. ; Nattam, Sreenivasa ; Hoke, Eva ; Cheson, Bruce D. ; Larson, Richard A.

British journal of haematology, 2014-04, Vol.165 (1), p.102-111 [Periódico revisado por pares]

Oxford: Blackwell

Texto completo disponível

Citações Citado por
7
Age-Specific Differences in Oncogenic Pathway Dysregulation and Anthracycline Sensitivity in Patients With Acute Myeloid Leukemia
Age-Specific Differences in Oncogenic Pathway Dysregulation and Anthracycline Sensitivity in Patients With Acute Myeloid Leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Age-Specific Differences in Oncogenic Pathway Dysregulation and Anthracycline Sensitivity in Patients With Acute Myeloid Leukemia

RAO, Arati V ; VALK, Peter J. M ; POTTI, Anil ; LÖWENBERG, Bob ; METZELER, Klaus H ; ACHARYA, Chaitanya R ; TUCHMAN, Sascha A ; STEVENSON, Marvaretta M ; RIZZIERI, David A ; DELWEL, Ruud ; BUSKE, Christian ; BOHLANDER, Stefan K

Journal of clinical oncology, 2009-11, Vol.27 (33), p.5580-5586 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
8
Autologous haematopoietic cell transplantation for non‐Hodgkin lymphoma with secondary CNS involvement
Autologous haematopoietic cell transplantation for non‐Hodgkin lymphoma with secondary CNS involvement
Material Type:
Artigo 		Adicionar ao Meu Espaço

Autologous haematopoietic cell transplantation for non‐Hodgkin lymphoma with secondary CNS involvement

Maziarz, Richard T. ; Wang, Zhiwei ; Zhang, Mei‐Jie ; Bolwell, Brian J. ; Chen, Andy I. ; Fenske, Timothy S. ; Freytes, Cesar O. ; Gale, Robert P. ; Gibson, John ; Hayes‐Lattin, Brandon M. ; Holmberg, Leona ; Inwards, David J. ; Isola, Luis M. ; Khoury, Hanna J. ; Lewis, Victor A. ; Maharaj, Dipnarine ; Munker, Reinhold ; Phillips, Gordon L. ; Rizzieri, David A. ; Rowlings, Philip A. ; Saber, Wael ; Satwani, Prakash ; Waller, Edmund K. ; Maloney, David G. ; Montoto, Silvia ; Laport, Ginna G. ; Vose, Julie M. ; Lazarus, Hillard M. ; Hari, Parameswaran N.

British journal of haematology, 2013-09, Vol.162 (5), p.648-656 [Periódico revisado por pares]

Oxford: Blackwell

Texto completo disponível

Citações Citado por
9
Phase II Feasibility and Pharmacokinetic Study of Concurrent Administration of Trastuzumab and High-Dose Chemotherapy in Advanced HER2+ Breast Cancer
Phase II Feasibility and Pharmacokinetic Study of Concurrent Administration of Trastuzumab and High-Dose Chemotherapy in Advanced HER2+ Breast Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase II Feasibility and Pharmacokinetic Study of Concurrent Administration of Trastuzumab and High-Dose Chemotherapy in Advanced HER2+ Breast Cancer

NIETO, Yago ; VREDENBURGH, James J ; JONES, Roy B ; SHPALL, Elizabeth J ; BEARMAN, Scott I ; MCSWEENEY, Peter A ; CHAO, Nelson ; RIZZIERI, David ; GASPARETTO, Christina ; MATTHES, Steve ; BARON, Anna E

Clinical cancer research, 2004-11, Vol.10 (21), p.7136-7143 [Periódico revisado por pares]

Philadelphia, PA: American Association for Cancer Research

Texto completo disponível

Citações Citado por
10
Bortezomib (VELCADE®) in metastatic breast cancer: pharmacodynamics, biological effects, and prediction of clinical benefits
Bortezomib (VELCADE®) in metastatic breast cancer: pharmacodynamics, biological effects, and prediction of clinical benefits
Material Type:
Artigo 		Adicionar ao Meu Espaço

Bortezomib (VELCADE®) in metastatic breast cancer: pharmacodynamics, biological effects, and prediction of clinical benefits

Yang, C. H. ; Gonzalez-Angulo, A. M. ; Reuben, J. M. ; Booser, D. J. ; Pusztai, L. ; Krishnamurthy, S. ; Esseltine, D. ; Stec, J. ; Broglio, K. R. ; Islam, R. ; Hortobagyi, G. N. ; Cristofanilli, M.

Annals of oncology, 2006-05, Vol.17 (5), p.813-817 [Periódico revisado por pares]

Oxford: Oxford University Press

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.